Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled RESTORE-CLI Trial
Molecular Therapy - United States
doi 10.1038/mt.2012.52
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2012
Authors
Publisher
Elsevier BV